Related Experiment Videos
Implantable cardioverter defibrillator lead technology: improved performance and lower defibrillation thresholds
1Cardiac Pacemakers, Inc., Guidant Corporation, St. Paul, Minnesota 55112, USA.
Pacing and Clinical Electrophysiology : PACE
|March 1, 1995
Summary
Optimizing implantable cardioverter-defibrillator (ICD) lead design is crucial for effective therapy delivery. Following four key engineering rules ensures optimal lead performance, improving patient outcomes and device reliability.
Area of Science:
- Biomedical Engineering
- Cardiovascular Devices
- Medical Device Design
Background:
- Implantable cardioverter-defibrillator (ICD) system performance relies heavily on lead functionality.
- Lead design involves engineering trade-offs impacting handling, durability, size, and therapy delivery.
- Preventing trade-offs from compromising therapy effectiveness is essential for low defibrillation thresholds.
Purpose of the Study:
- To outline fundamental engineering design rules for enhancing ICD lead efficacy.
- To guide the design process for optimal current delivery and lead efficiency.
- To improve the overall performance and reliability of ICD systems.
Main Methods:
- Description of four basic design rules for ICD lead engineering.
- Focus on optimizing current delivery to the heart.
- Emphasis on enhancing the lead and electrode interface efficiency.
Main Results:
- Minimizing electrode pullback enhances efficacy.
- Directing current to the cardiac apex improves therapy delivery.
- Reducing energy loss within the lead is critical.
- Utilizing large, efficient electrodes maximizes performance.
Conclusions:
- Adherence to these design rules optimizes current delivery and lead efficiency.
- Effective lead function contributes to optimal safety margins for implantation.
- Improved lead design enables a greater number of patients to benefit from single-lead ICD systems.